Supplement
See all supplementsLiver cancer
Vol. 516 No. 7529_supp ppS1-S48
In this Supplement
Liver cancer is one of the most lethal forms of the disease: only 19% of those who have it survive a year after diagnosis, even with treatment, and there are few promising therapies in the pipeline. But if researchers can understand why some people with unhealthy livers develop cancer but others do not, they may be able to treat the disease more effectively — or even prevent it.
Cover Art: Katie Scott
